key: cord-0826805-mpjvwver authors: Zhou, Feng; Hu, Tao-Jun; Zhang, Xiao-Yu; Lai, Keng; Chen, Jun-Hu; Zhou, Xiao-Hua title: The association of intensity and duration of non-pharmacological interventions and implementation of vaccination with COVID-19 infection, death, and excess mortality: natural experiment in 22 European countries date: 2022-03-24 journal: J Infect Public Health DOI: 10.1016/j.jiph.2022.03.011 sha: b06fee65efe001632eba9f92bc4aed0f60481a68 doc_id: 826805 cord_uid: mpjvwver BACKGROUND: Critical questions remain regarding the need for intensity to continue NPIs as the public was vaccinated. We evaluated the association of intensity and duration of non-pharmaceutical interventions (NPIs) and vaccines with COVID-19 infection, death, and excess mortality in Europe. METHODS: Data comes from Our Word in Data. We included 22 European countries from January 20, 2020, to May 30, 2021. The time-varying constrained distribution lag model was used in each country to estimate the impact of different intensities and duration of NPIs on COVID-19 control, considering vaccination coverage. Country-specific effects were pooled through meta-analysis. RESULTS: This study found that high-intensity and long-duration of NPIs showed a positive main effect on reducing infection in the absence of vaccines, especially in the intensity above the 80th percentile and lasted for 7 days (RR=0.93, 95% CI: 0.89 to 0.98). However, the adverse effect on excess mortality also increased with the duration and intensity. Specifically, it was associated with an increase of 44.16% (RR=1.44, 95% CI: 1.27 to 1.64) in the excess mortality under the strict intervention (the intensity above the 80th percentile and lasted for 21 days). As the vaccine rollouts, the inhibition of the strict intervention on cases growth rate was increased (RR dropped from 0.95 to 0.87). Simultaneously, vaccination also alleviated the negative impact of the strict intervention on excess mortality (RR decreased from 1.44 to 1.25). Besides, maintaining the strict intervention appeared to more reduce the cases, as well as avoids more overall burden of death compared with weak intervention. CONCLUSIONS: Our study highlights the importance of continued high-intensity NPIs in low vaccine coverage. Lifting of NPIs in insufficient vaccination coverage may cause increased infections and death burden. Policymakers should coordinate the intensity and duration of NPIs and allocate medical resources reasonably with widespread vaccination. As of March 06, 2022, it has been nearly 2 years since WHO declared the COVID-19 outbreak a pandemic (1) . Over 4.43 billion confirmed cases and 5.99 million total deaths have been reported in Europe during this pandemic (2) . Many European healthcare facilities had adopted various measures to prevent and control the pandemic, especially non-pharmaceutical interventions (NPIs) and vaccination. As a new and highly contagious disease, NPIs are an essential component of epidemic prevention and control in the absence of effective treatment regimens, such as physical distancing and traffic restriction (3) (4) (5) (6) (7) . Most of the previous researches on the effectiveness of specific NPIs came from modelling studies (8) (9) (10) (11) and there was little research based on real-world research (12) (13) (14) . Besides, these existing evidences only focused on the changes in health outcomes before and after interventions implementation, which treated the intervention as a break-point (12, 15) . Obviously, in the context of a prolonged pandemic, due to the insufficient medical resources, the intensity of interventions changes dynamically, and they have cumulative and lagging effects on epidemic prevention and control. Meanwhile, post-introduction vaccines J o u r n a l P r e -p r o o f may also vary the effects of NPIs (16) (17) (18) (19) . Therefore, critical questions remain concerning the need for intensity to continue NPIs as the public was vaccinated. It is important to explore the effects of the intensity and duration of NPIs and the interactive impact of the vaccine on epidemic prevention and control, which provides guidance for policymakers in the allocation of medical resources, specifically in resource-scarce periods or regions. In addition, existing studies often adopted indicators that reflect the status of the epidemic as the outcome, such as effective transmission rate and the number of cases, etc. (12-14, 20, 21) . However, the other impacts caused by pandemics were ignored, such as excess mortality. Excess mortality is a more comprehensive measure of the total impact of the COVID-19 pandemic on deaths. It refers to the number of deaths from all causes during pandemic above and beyond what we would have expected to see under 'normal' conditions, including the deaths from other causes that are attributed to the transfer and lack of medical resources and negative of strong restrictive intervention during the pandemic (22) (23) (24) (25) (26) . Therefore, excess mortality also should be considered to comprehensively identify the impact of the intensity and duration of NPIs and vaccination on the prevention and control of the epidemic. In this study, we aimed to evaluate the independent and added effects of intensity and duration of interventions on the prevention and control of the pandemic in Europe, including on new cases, new COVID-19 death, and excess mortality. We further assessed the changes of these effects after the implementation of vaccine policies and the independent effects of vaccination. countries because excess mortality data were not available, and 11 countries since missing data on excess mortality (less than 60 records were available). Similarly, three countries were excluded due to unavailability of Containment and Health Index (CHI). In addition, we exclude 3 countries with a small total population (less than 1 million). The details of sampling countries and flow chart are shown in Figure 1 . The indicators for evaluating the intensity of NPIs using the CHI, a composite measure of twelve of the response metrics (0-100). This index was calculated using these metrics such as school closures; workplace closures; cancellation of public events; restrictions on public gatherings; closures of public transport; stay-at-home requirements; public information campaigns; restrictions on internal movements; and international travel controls; testing policy; the extent of contact tracing; requirements to wear face coverings. In addition, we also focus on the vaccinations against COVID-19, which was obtained from Our World in Data, published by Oxford University (29) . From the COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University, we collected data on the number of daily new confirmed cases and deaths in these countries. Data on excess mortality during the pandemic was sourced from the Human Mortality Database and the UK Office for National Statistics. Other populations and demographic data like population density were from World Bank, and gross domestic product (GDP) per capita was J o u r n a l P r e -p r o o f from International Monetary Fund, and hospital beds per thousand were from Eurostat, World Bank, national government records, and other sources (30). We adopted different definitions of strong interventions (SI) based on intensity criterion (60th, 65th, 70th, 75th, and 80th percentiles) and duration (5, 7, 10, 14 , and 21 days) of CHI in each country. Besides, we consider the role of vaccination coverage that people fully vaccinated. According to the current status of people vaccinated, delay in antibody production, and date availability, we separately analyzed the association between the NPIs and the three main outcomes under different vaccine coverage rates (0%, 10%, 20%). There are three main outcomes of interest in this study. Firstly, we define the cases growth rate by calculating the percentage difference between the current number of daily new cases and the number of daily new cases the day before. Secondly, the death growth rate has also been calculated by the same method. Thirdly, we measure excess mortality using the P-score, which is the percentage difference between the number of deaths in 2020-2021 and the average number of deaths in the same week over the years 2015-2019 (23). We applied a two-stage time series model to specify the effects of NPIs and vaccination to our main outcomes of interest. To subdivide the effects as for NPIs, we defined the main effect as the independent impact of daily strong interventions and the added effect as the added risk due to the duration of NPIs, which was quantified according to different definitions of strong interventions. In the first stage regression model, we adopted a linear regression with constrained distributed lag model (31) to estimate main effect, added effect and effect of vaccination policy. For each country, we specify the linear model as, P ~Normal(μ , σ 2 ) μ = α 0 + cb( , lag) + β + γVaccination , for which denotes the value of outcomes of interests on day . is the evaluated CHI on day , which takes values from 0 to 100; ( , lag) is the cross-basis function to fit the accumulative association of non-pharmacological interventions on 0 − days. is a binary indicator of strong interventions on day ; Vaccination is another binary variable to represent whether the fully vaccinated people have covered a predetermined percentage of total population up to day . α 0 is the country-specific intercept which is time invariant but varies from the countries. β is the coefficient of SI, corresponding to the added effect and γ indicates the effect of vaccination policy. Through a pre-analysis of linear models, we observed heteroskedasticity of which σ 2 may vary with time, specified as σ 2 . We accounted for the heteroskedasticity with a linear regression between (σ 2 ) and the daily accumulative infections of COVID-19. In the linear regression with constrained distributed lag model above, we left a tuning parameter to be determined through a model selection procedure. Selecting the tuning parameter from 1 to 10, we fitted the model respectively. The optimal tuning parameter was decided according to the model performance measured by Akaike information criterion (AIC). The lower estimation of suggested that the outcome depended on a shorter period of cumulative interventions. For the second stage analysis, we pooled all results of 22 European countries using a random-effect meta-analysis. We considered the population density, hospital beds per thousand, and GDP per capita of each country as the moderators to conduct the meta-analysis. All statistical analyses were conducted using R software (version 4.1.0). P<0.05 was considered statistically significant. During the pandemic from January 20, 2020, to May 30, 2021, the average days of strong intervention in 22 countries have gradually decreased as the definition of strong interventions becomes stricter (Table 1) . Specifically, the average days were more than half of the days (58.98%) under the definition of low threshold (60th percentile) and low duration (5 days). Even with the strict intervention (80th percentile and duration 21 days), the average days that strong interventions lasted accounted for above one-third (35.28%) during the pandemic. Similarly, the independent impact of vaccination on case growth rate was not significant, except when the vaccine was just introduced it played an independent role in increasing the case growth rate. As we can see in the middle line of Table 2 and Figure Figure S1 and Figure S2 detail the association between the strict and weak intervention and the three main outcomes after vaccination rollouts in each country during the pandemic, respectively. As we can see in Figure S1a , Figure S1c ). In addition, details of these effects of the weak intervention after vaccination rollouts in each country see Figure S2 . Our findings suggest that high-intensity and long-duration of NPIs were associated with a decreased daily new cases growth rate before the implementation of the vaccine policies. However, it is also associated with an increase in excess mortality without affecting the COVID-19 death growth rate. Moreover, our study highlights the importance of continued high-intensity NPIs in low vaccine coverage. After the implementation of the vaccine policies, the inhibition of strict intervention on cases growth rate was increased (RR decreased from 0.95 to 0.87), which may be affected J o u r n a l P r e -p r o o f by the interaction of vaccines. Simultaneously, vaccine policies also alleviated the negative impact of strict intervention on excess mortality (RR dropped from 1.44 to 1.25). Furthermore, maintaining strict intervention after vaccination rollouts appeared to more reduce the incidence of new cases, as well as avoids more overall burden of death compared with the weak intervention. In addition, we found that vaccines have independent protection in reducing total deaths even if in the low vaccine coverage rate. This study not only confirms the previous finding that combined NPIs were beneficial effects on control the infection (4-6, 12, 32) such as physical distancing (8) and traffic restrictions (33, 34) etc., but also highlights the role of intensity and duration of NPIs in absence of vaccines. A modelling study from 16 worldwide countries speculated that dynamic interventions could provide means to reduce the effective reproduction number and keep ICU demands below the national capacities (35) . Our retrospective study also verified that despite the intervention intensity was only more than the 60th percentile, if it lasted for 21 days, it appeared to achieve a similar effect as above the 80th percentile intensity for 7 days in reducing infections. However, this did not mean that long-term continuous lower-intensity interventions were feasible, because it may result in some potential adverse effects, such as an increase in excess mortality instead of COVID-19 deaths. Unlike previous model-based studies, in which NPIs could reduce the COVID-19 deaths (4, 32), our study from real-world did not find this possibly due to the different periods of analysis. In addition, increased excess mortality could be partly explained by increased deaths from other causes during long-term constraints, such as the inability to seek medical attention in time and weakened healthcare systems (22) (23) (24) (25) 36) . Thus, our study suggests that, it is crucial to comprehensively consider the control infection and death J o u r n a l P r e -p r o o f burden in the introduction and implementation of NPIs. Further, our study also found, the longer duration of low-intensity interventions indirectly implied the health facilities were inactive and incapable in responding to the epidemic, which could result in more excess deaths. Although high-intensity interventions had also independently caused a considerable increase in excess deaths. However, in the long run, the cumulative impact on excess deaths would be reversed, which may be due to the delayed effect of NPIs and this effect diminishes gradually over time (21) . Under this situation, we speculated the contribution of added effects of high-intensity interventions on excess mortality may make up for the main effects. These findings were not mentioned in previous studies and it revealed the significance of long-term continuous high-intensity interventions before the vaccination rollouts from a novel perspective. Our research confirms that the role of vaccine policies in epidemic prevention and control, which were similar to previous studies conducted in Israel (37) and England (38) , and based on modelling (16, 17, 19) . Surprisingly, we found that the strict intervention was better than the weak intervention to control case growth in low vaccine coverage, the latter has no statistical association with case growth rate. other factors (such as old-age-related diseases) after the first and second waves of the epidemic (22, 40, 41) . In addition, the impact of the same intensity and duration of interventions on excess mortality has been reduced after vaccination rollouts. This may result from that the vaccination makes the allocation of limited medical resources more reasonable and alleviates the lack of medical resources (19) , and thus reduced excess deaths. Notably, the excess mortality caused by the weak intervention was greater than strict intervention, and the latter can effectively control cases than the former. This also insinuates lifting or removing of NPIs may increase the death burden in the case of insufficient vaccine coverage. These findings provide additional evidence for policymakers on the lifting of NPIs after the vaccination program. This study focused on the duration and intensity of NPIs on COVID-19 the prevention and control and we pooled data and summarized experience from included 22 countries in the past nearly 15 months. At the same time, we reported the effects of vaccines from real-world data and gave an inspiration from the perspective of excess mortality. However, there are some limitations. First, the association between NPIs and outcome was not a causal effect in this study, which may be affected by unobserved confounding. We have considered as many observable confounding as possible, such as population size, GDP, and other factors. Second, this study cannot clarify which intervention was more effective. This has been researched in many previous studies (5) (6) (7) (8) 42) , and further research is needed to provide answers to this question based on real-world data using other statistical analysis. Third, our research was based on the national-level, therefore we were unable to provide a reasonable explanation regarding the association between NPIs and health outcomes at the individual-level, such as adherence of individual behavior. Finally, this study only analyzed 22 European countries since missing data. This non-random sampling may make the sample less representative. Therefore, this study cannot generalize the whole of Europe. In World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 -11 COVID-19) Dashboard. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. 2022 Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis Impact of non-pharmaceutical interventions for reducing transmission of COVID-19: a systematic review and meta-analysis protocol Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19 Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories Impact of National Containment Measures on Decelerating the Increase in Daily New Cases of COVID-19 in 54 Countries and 4 Epicenters of the Pandemic: Comparative Observational Study The Impact of the Social Distancing Policy on COVID-19 Incidence Cases and Deaths in Iran from Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios -United States Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study Our World in Data. Excess mortality during the Coronavirus pandemic (COVID-19) Excess all-cause mortality during the COVID-19 pandemic in Europe -preliminary pooled estimates from the EuroMOMO network Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries Indirect implications of COVID-19 prevention strategies on non-communicable diseases : An Opinion Paper of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk Assessment in Subjects Living in or Emigrating from Low Resource Settings Coronavirus Government Response Tracker. Policy Responses to the Coronavirus Pandemic Our World in Data. Coronavirus (COVID-19) Vaccinations. 2021 Our World in Data. Data on COVID-19 (coronavirus) by Our World in Data Temporal Variation in Heat-Mortality Associations: A Multicountry Study State-level needs for social distancing and contact tracing to contain COVID-19 in the United States International travel-related control measures to contain the COVID-19 pandemic: a rapid review Travel-related control measures to contain the COVID-19 pandemic: a rapid review Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study comparing 16 worldwide countries Excess mortality during the COVID-19 outbreak in Italy: a two-stage interrupted time-series analysis Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study Emergence of SARS-CoV-2 B.1.1.7 Lineage -United States Real-time monitoring The authors gratefully acknowledge the excellent support of Our World in Data and the data collection team at Oxford University.